Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer - Related Studies

Home

Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

This study has been completed.

Study NCT00113334. Last updated on October 30, 2008. Information provided by M.D. Anderson Cancer Center

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		ABT-510

5	Sponsors listed in this trial
		M.D. Anderson Cancer Center
		Abbott